For a study involving eclampsia treatment in pregnant women, from whom must consent be obtained?

In research involving pregnant women, consent must be obtained directly from the pregnant woman herself. This aligns with the ethical principles protecting individuals participating in biomedical research, particularly the emphasis on autonomy and informed consent. Pregnant women are considered capable of providing informed consent for their participation in studies, as they can understand the information about the study, its risks, and benefits.

Obtaining consent from the pregnant woman ensures that she is actively involved in decisions regarding her health care and that of her fetus. While there may be ethical considerations involving the father of the fetus in discussions about the treatment or pregnancy, the primary individual responsible for providing consent in a clinical research setting is the pregnant woman.

Other options may introduce the idea of securing consent from additional parties, such as legally authorized representatives or the father of the fetus, but the primary ethical guideline in biomedical research focuses on obtaining consent from the participant directly involved, which in this case is the pregnant woman.